Orchestra BioMed Holdings, Inc. Enters Material Definitive Agreement
Ticker: OBIO · Form: 8-K · Filed: Aug 4, 2025 · CIK: 1814114
| Field | Detail |
|---|---|
| Company | Orchestra Biomed Holdings, Inc. (OBIO) |
| Form Type | 8-K |
| Filed Date | Aug 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, corporate-event
TL;DR
Orchestra BioMed signed a big deal on 7/31/25.
AI Summary
On July 31, 2025, Orchestra BioMed Holdings, Inc. entered into a Material Definitive Agreement. The company, formerly known as Health Sciences Acquisitions Corp 2, is incorporated in Delaware and headquartered in New Hope, Pennsylvania.
Why It Matters
This filing indicates a significant new contract or partnership for Orchestra BioMed Holdings, Inc., which could impact its future business operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can introduce new risks related to the terms of the agreement, counterparty performance, and integration challenges.
Key Players & Entities
- Orchestra BioMed Holdings, Inc. (company) — Registrant
- Health Sciences Acquisitions Corp 2 (company) — Former company name
- July 31, 2025 (date) — Date of earliest event reported
- New Hope, Pennsylvania (location) — Principal executive offices
FAQ
What type of Material Definitive Agreement did Orchestra BioMed Holdings, Inc. enter into?
The filing does not specify the exact nature of the Material Definitive Agreement, only that one was entered into on July 31, 2025.
When was Orchestra BioMed Holdings, Inc. formerly known as Health Sciences Acquisitions Corp 2?
The company changed its name from Health Sciences Acquisitions Corp 2 on June 3, 2020.
Where are Orchestra BioMed Holdings, Inc.'s principal executive offices located?
The principal executive offices are located at 150 Union Square Drive, New Hope, Pennsylvania 18938.
What is the SIC code for Orchestra BioMed Holdings, Inc.?
The Standard Industrial Classification code is 3841, for Surgical & Medical Instruments & Apparatus.
What is the fiscal year end for Orchestra BioMed Holdings, Inc.?
The fiscal year end for Orchestra BioMed Holdings, Inc. is December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 4, 2025 regarding Orchestra BioMed Holdings, Inc. (OBIO).